Amid growing concerns in the United States, health authorities are warning pregnant women about the use of paracetamol in pregnancy, known in Denmark as Panodil, Pamol, and Pinex, due to a suspected link to autism. Danish health agencies, however, maintain current guidelines, stressing that no direct causal connection has yet been proven.
American Warnings Against Tylenol Use in Pregnancy
In a joint press conference at the White House, former U.S. President Donald Trump and Health Secretary Robert F. Kennedy Jr. issued a stark warning to pregnant women regarding the use of the common painkiller Tylenol. The medication, whose active ingredient acetaminophen is known as paracetamol in Europe, was linked by the pair to a rising autism rate among children in the U.S.
Although the scientific foundation remains contested, the U.S. Food and Drug Administration (FDA) cited earlier studies suggesting a possible association between prenatal exposure to paracetamol and neurodevelopmental disorders such as autism and ADHD. In response, the U.S. Department of Health and Human Services (HHS) has announced it will begin adding safety warnings to packaging of paracetamol-based medications.
Danish Equivalents and Current Recommendations For Paracetamol in Pregnancy
In Denmark, paracetamol is widely used under brand names such as Panodil, Pamol, and Pinex. While warnings in Denmark have traditionally focused on avoiding ibuprofen-based products like Ipren and Ibumetin during pregnancy due to risks of miscarriage, paracetamol had generally been considered a safer alternative.
However, these new alerts have sparked questions about whether Danish health authorities should revise current guidelines. So far, both the Danish Medicines Agency and the National Board of Health have stated that there is insufficient scientific evidence to support a link between paracetamol use during pregnancy and autism in children.
Previous Research and Expert Opinions
Concerns over paracetamol use during pregnancy are not entirely new. In 2021, an international group of 13 scientists, including multiple researchers from Denmark’s Rigshospitalet, issued a cautionary statement, urging pregnant women to use paracetamol only when medically necessary. According to the researchers, excessive use could potentially pose risks to fetal development.
The team further recommended that women planning pregnancy be particularly cautious. A Danish animal and laboratory study published in 2023 found that paracetamol could disrupt early-stage cell division by interfering with DNA synthesis. This research added weight to the precautionary stance many scientists now advocate.
Mixed Results and Lack of Causal Proof On Impact Of Use of Paracetamol in Pregnancy
Despite public concern, the scientific consensus remains mixed. Of about 47 global studies conducted on the topic, approximately half show a link between paracetamol use during pregnancy and developmental disorders such as autism or ADHD. Among these is a 2016 Danish study that reported a statistically significant association.
However, the other half of studies, such as a major Swedish population-based analysis of over two million children, found no such connection. Experts point out that a correlation observed in studies does not necessarily equate to causation, a key concept in epidemiology. Without a direct biological mechanism to explain how paracetamol might cause autism, experts agree that more research is needed.
Healthcare Guidance in Denmark Remains Steady
Danish authorities have not altered their official guidance based on the American warnings. The Danish Medicines Agency emphasizes that pregnant women should continue to follow existing advice: use the lowest effective dose of paracetamol for the shortest period possible and always consult a healthcare professional before use.
The European Medicines Agency (EMA) has echoed this position, stating as of September 2025 that there are no changes to labels or usage recommendations for paracetamol in pregnancy across the EU.
A New Autism Treatment Sparks Debate
In a controversial move, the U.S. has granted approval for the cancer drug Leucovorin to be used in children on the autism spectrum, despite the lack of large-scale research supporting its effectiveness for this purpose. The approval came even as the U.S. National Institutes of Health (NIH) announced it will only now begin formal clinical trials.
Experts warn against jumping to conclusions based on incomplete data, advising caution both in prescribing treatments and issuing public health announcements — especially those that could cause unnecessary anxiety among expectant mothers.
Conclusion On Paracetamol in Pregnancy
While American officials ring alarm bells over paracetamol in pregnancy, the medical community continues to debate its potential link to autism. Danish health authorities, backed by EU health bodies, recommend using the medication only when necessary, but see no cause yet for drastic policy change. As research progresses, pregnant women worldwide are urged to consult their doctors before taking any form of pain relief.
